Viridian Therapeutics, Inc.

NASDAQ:VRDN

Biotechnology

Healthcare
$31.44 -0.88%

-$0.15 today

Market cap
$3.57B
Beta
0.90
P/E (TTM)
-4.7
EPS (TTM)
-$3.53
52W Low $13.18High $34.29

Volume 4.02M

Average 2.86M

Price history

Viridian Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+6.68%

Period high

$33.78

Period low

$13.30

Latest

$31.44

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
8-KNov 9, 2026Nov 9, 2026
10-QNov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
4Aug 20, 2026Aug 20, 2026
SC 13GAug 20, 2026Aug 20, 2026
4Aug 18, 2026Aug 18, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
SC 13GAug 7, 2026Aug 7, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
4Jul 2, 2026Jul 2, 2026

Competitors

Who does Viridian Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about VRDN's filings, answered from its disclosures.

What is the latest VRDN filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does VRDN have?

Intrinsic Alpha currently shows 20 recent filings for VRDN.